interferon
among
biolog
activ
known
substanc
protein
natur
product
eukaryot
ceil
expos
specif
induc
best
known
viru
infect
interferon
protect
cell
effect
viru
replic
inhibit
format
new
infecti
viru
particl
howev
protect
gener
speak
confer
cell
speci
interferon
produc
although
antivir
effect
first
properti
interferon
recognis
subsequ
studi
reveal
mani
activ
includ
inhibit
cell
growth
divis
modul
immun
respons
humor
cell
mediat
three
type
interferon
interferon
leucocyt
interferon
fl
fibroblast
possess
mani
similar
although
antigen
distinct
interferon
immun
differ
interferon
fl
mani
physic
chemic
biolog
activ
well
antigen
suppli
human
interferon
limit
past
need
human
ceil
product
earli
prepar
suffer
disadvantag
contain
actual
interferon
last
year
recombin
dna
technolog
permit
product
human
interferon
microorgan
improv
techniqu
togeth
use
monoclon
antibodi
result
prepar
high
degre
puriti
appli
three
type
interferon
also
number
twenti
subtyp
interferon
known
exist
sinc
genet
engin
highli
purifi
interferon
avail
short
time
much
report
work
interferon
viral
infect
perform
interferon
produc
leucocyt
buffi
coat
human
blood
human
fibroblast
howev
trial
new
interferon
prepar
confirm
activ
observ
earlier
crude
product
result
interferon
contain
caus
impur
influenza
infect
human
product
interferon
parallel
clinic
symptom
viru
excret
time
antibodi
detect
interferon
virtual
disappear
circul
suggest
interferon
play
import
role
limit
recoveri
viru
infect
interferon
effect
practic
virus
make
antivir
great
clinic
potenti
obvious
indic
replac
therapi
one
reason
anoth
produc
littl
interferon
shown
occur
children
abnorm
suscept
upper
respiratori
tract
infect
also
instanc
fulmin
hepat
give
exogen
interferon
appear
activ
patient
interferon
product
latter
observ
may
exampl
prime
induct
cell
pretreat
small
quantiti
interferon
produc
greater
quantiti
interferon
stimul
cell
without
prior
exposur
interferon
antivir
effect
mediat
protect
noninfect
cell
direct
action
viru
particl
interferon
prophylact
effect
probabl
greater
therapeut
action
intraderm
interferon
prevent
take
subsequ
inocul
vaccinia
viru
interferon
given
intranas
viru
challeng
protect
volunt
infect
rhinoviru
coronaviru
system
interferon
shown
reduc
incid
herpet
lesion
excret
herp
viru
follow
section
trigemin
nerv
treatment
tic
douloureux
also
delay
excret
cytomegaloviru
cmv
urin
reduc
incid
cmv
viraemia
renal
transplant
patient
prolong
prophylaxi
also
reduc
clinic
manifest
cmv
infect
patient
establish
acut
viral
infect
result
less
encourag
case
herp
simplex
viru
infect
lead
dendrit
ulcer
cornea
interferon
alon
littl
effect
combin
wipe
debrid
thermocauteri
trifluorothymidin
effect
treatment
alon
interferon
influenc
cours
zoster
normal
individu
immunosuppress
appear
endogen
interferon
delay
infect
like
becom
dissemin
interferon
reduc
incid
seriou
complic
postherpet
neuralgia
addit
shorten
period
acut
phase
pain
experienc
new
lesion
appear
similar
less
conclus
result
obtain
follow
interferon
treatment
varicella
children
suffer
malign
interferon
therapi
also
tri
chronic
infect
notabl
hepat
b
viru
quit
dramat
reduct
elimin
circul
marker
hepat
b
viru
achiev
interferon
howev
may
requir
repeat
cours
without
synthet
antivir
success
obtain
proport
patient
furthermor
phenomenon
known
occur
spontan
untreat
case
treatment
congenit
rubella
cytomegaloviru
infect
result
consist
clinic
improv
although
reduct
viral
replic
achiev
wart
much
rarer
juvenil
laryng
papilloma
result
infect
papiuomavirus
wart
respond
interferon
appli
local
system
interferon
halt
progress
laryng
papilloma
prevent
recurr
surgic
remov
mean
certain
interferon
activ
antivir
growth
inhibit
immunomodulatori
respons
effect
observ
case
result
summar
repres
modest
success
substanc
herald
ideal
antivir
recognis
year
progress
slow
mainli
limit
suppli
interferon
avail
recent
restrict
number
trial
furthermor
optim
dosag
either
prophylact
therapeut
determin
trial
error
exampl
known
critic
concentr
interferon
frequenc
administr
intranas
interferon
fail
protect
experiment
rhinoviru
infect
benefici
effect
interferon
zoster
patient
malign
directli
relat
amount
given
unfortun
becom
appar
even
highli
purifi
interferon
toxic
one
million
unit
given
system
result
fever
headach
malais
medic
continu
induc
anorexia
fatigu
dosag
also
depress
bone
marrow
affect
liver
function
even
given
topic
nasal
mucosa
period
time
greater
day
mild
inflammatori
chang
occur
prevent
use
longterm
prophylaxi
howev
much
work
need
done
interferon
discard
mainli
academ
interest
littl
clinic
import
virtual
trial
perform
interferon
mani
interferon
subtyp
possibl
one
may
greater
antivir
toxic
ratio
alreadi
studi
known
synerg
exist
differ
type
subtyp
interferon
would
seem
worthwhil
explor
view
fact
greatest
success
therapi
far
achiev
interferon
combin
synthet
antivir
p
g
higgin
mrc
common
cold
unit
coomb
road
salisburi
wiltshir
england
